PISA® Farmacéutica is a 100% Mexican company with a 78 year history. We specialize in developing comprehensive products and services for both the public and private healthcare sectors, extending our reach to Mexico, the United States, Latin America, and the Caribbean.
Over the past seven decades, the growth of PISA® Farmacéutica has been driven by our invaluable human capital. We are committed to excellence, recognizing that each of our actions is guided by our overarching purpose: “A Life at the Service of Life”.
Our strong production capabilities and breadth of knowledge in the Mexican and Latin American markets at PISA® Farmacéutica have not only molded the course of our development but also cleared the path for our prosperous global expansion.
We are a Socially Responsible Enterprise (ESR). With this, we confirm our permanent commitment to society, the environment, our employees, and their families.
For 14 consecutive years, PISA® Farmacéutica has held the ESR Distinction from the Mexican Center for Philanthropy (Cemefi) and was recognized by Tops Mexico within the ranking of “The Best Socially Responsible Companies in Mexico”, which lists the 200 companies that help and contribute the most to the country.
We are a Socially Responsible Enterprise (ESR). With this, we confirm our permanent commitment to society, the environment, our employees, and their families.
For 14 consecutive years, PISA® Farmacéutica has held the ESR Distinction from the Mexican Center for Philanthropy (Cemefi) and was recognized by Tops Mexico within the ranking of “The Best Socially Responsible Companies in Mexico”, which lists the 200 companies that help and contribute the most to the country.
We are a group of reputable, trustworthy, morally minded businesses that are committed to providing excellent customer service, employee welfare, and health promotion.
To achieve lasting impact through innovation, foster accelerated growth both in Mexico and beyond.
lnauguration of the large volume Parenteral Solutions Production Plant located at Calle 7 of the Industrial Zone in Guadalajara, Jalisco.
PiSA® Farmacéutica starts manufacturing large-volume parenteral solutions in polyethylene FLEXOVAL® packaging. Using the same technology, PiSA® Farmacéutica produces plastic ampoules and is currently the largest manufacturer of these two types of products in the Mexican market.
The first Mexican manufacturer of products for Ambulatory Peritoneal Dialysis.
Inauguration of the new Cephalosporin Antibiotics and Penicillin Antibiotics Plant in Guadalajara, Jalisco. PiSA® Farmacéutica becomes the first to develop and operate a network of Mixing Centers in Mexico. PiSA® Agropecuaria begins operations.
PiSA® Farmacéutica becomes the first laboratory in the Latin American pharmaceutical industry to adopt a LIMS (a Laboratory Information Management System). PiSA® Farmacéutica Colombia begins operations.
PISA® Farmacéutica is ISO 9001-certified by the French Association for Quality Assurance (AFAQ) for all its sites.
The Oncology Products Plant was inaugurated in Mexico City.
Inauguration of the new PyMPSA® plant, specialized in the manufacturinge of Healing Equipment and Materials. PiSA® Farmacéutica El Salvador and PiSA® Farmacéutica Guatemala begins operations.
PISA® Farmacéutica begins operations in the prescription drug market.
The first company to install the BOSCH Aseptic Glass Ampoule Packaging Line with "Isolator Technology" in Mexico.
Inauguration of the Hormonal Products Plant in Guadalajara to produce tablets, injectable solutions, and injectable suspensions.
Galia Textil obtains ISO 9002 certification from the ABF Quality Evaluation of the United States.
PiSA® Farmacéutica Panama begins operations.
PISA® Farmacéutica obtains the Clean Industry certification for all its production plants.
PISA® Farmacéutica obtains ISO 9001:2000 certification from the Spanish Association for Standardization and Certification (AENOR).
SANEFRO® , Integral Nephrology Services, begins operations. PISA® Farmacéutica enters the North American market.
PiSA® Farmacéutica incorporates its new institutional image for prescription products.
PiSA® Farmacéutica innovates, develops, and launches the first electro-medical equipment for Automated Peritoneal Dialysis (APD), PD PACIFICA® , of its manufacture; this is considered by the National Council of Science and Technology (CONACYT) as an important innovation in the field of Mexican Nephrology. The LEAN philosophy is incorporated in the PyMPSA® and PiSA® Farmacéutica plants.
A new plant begins operations in Jalisco, with its first stage dedicated to the manufacturing of dialysis solutions.
The use of a new methodology to perform sterility testing of injectable products by rapid method (RMM) and isolator technology begins. With this, Mexico becomes the first country in Latin America to have this state-of-the-art technology of its kind.
The second stage of the Tlajomulco plant begins operations. The production of plastic (polyethylene) ampoules begins in Tlajomulco. Electrolit® is relaunched with a modern and dynamic image. PISA® Farmacéutica is certified as a Socially Responsible Company (ESR) by Cemefi.
The Electrolit® production line starts operations in Tlajomulco. The third production line of Peritoneal Dialysis Bags , two lines of Flexoval® 1000 ml (Blow-Fill-Seal) , a first production line of Solid Forms (uncoated tablets) and a first production line of lyophilized vials (non-oncological, first lyophilizer) begins operations in the Tlajomulco complex.
The In the Tlajomulco complex, the Own Brand Product Packaging Plant begins operations.
The first production line of Polypropylene Ampoules (diluents) begins operations. The second production line for Solid Forms (uncoated tablets) begins operations in Tlajomulco. The pilot plant (development products) begins operations in the Industrial zone of Guadalajara, Jalisco.
PyMPSA® successfully implements the Operational Excellence Culture with the Shingo Silver Award. The first Flexoval® 100ml (Blow-Fill-Seal) production line begins operations in Tlajomulco. The first Electrolit® production line begins operations in Tlajomulcoand. Two Lyophilized Vials production lines (non-oncological, second, and third lyophilizers) begin operations in Tlajomulco.
PiSA® Farmacéutica celebrates its 70th anniversary. The third and fourth production line of Solid Forms (coated tablets and uncoated tablets) begins operations in Tlajomulco. The National Distribution Center (NDC) begins operations in Tlajomulco, and Two Peritoneal Dialysis lines (fourth and third lines) begin operations in Tlajomulco. The first Cephalosporin line begins operations at the plant located in the Jalisco Industrial Area.
The National Distribution Center (NDC) begins operations in Tlajomulco.
The Bodylogic Food Supplements Plant is inaugurated in Tlajomulco.
PiSA® Farmacéutica celebrates 75 years of history in the Mexican and Latin American markets and reaffirms its commitment to families to continue producing quality, safe, and efficient medicines. The construction of two new Oncology and Immunosuppressant plants with High Containment and Digital Integration with technology: High Containment, Pharma Digital, and Pharma 4.0. Grupo PiSA® currently has 16 production plants throughout Mexico.
PISA® Farmacéutica is a company dedicated to the manufacturinge, commercialization, and distribution of medicines and medical devices for the treatment of a wide range of health issues, such as nephrology, infectious diseases, anesthesiology, etc.
At PISA® Farmacéutica we work daily to maintain the Good Manufacturing Practices in the Life Cycle of our products through our team of collaborators and state-of-the-art technology used in all processes, with the purpose of complying with the quality, safety, and efficacy profile established by the Health Authorities through laws, regulations, standards, and technical-scientific guidelines.
Thus, the PiSA Farmacéutica Quality Policy statement is committed to:
Certifications granted by the national and foreign Ministries of Health are within the scope of operations of PISA® Farmacéutica, as well as by internationally recognized pharmaceutical organizations:
• Being available to learn and teach.
• Knowing how to listen.
• Acknowledging mistake.
• Treating clients and suppliers unostentatiously.
• Treating others the way you would like to be treated.
• Achievements team sharing.
• Telling always the truth on an objective and complete basis, as well as without justifications.
• Looking after the company information.
• Having the duty for reporting bad practices and behaviors.
• Not wasting time on working schedule.
• Choosing the best for the company.
• Giving fair recognition to those who work and to those who do not work.
• Knowing that stringency does not enter into conflict with good treatment.
• Avoiding favoritism.
• Considering everybody’s time.
• Giving each person his due.
• Being responsible for the consequences of our actions.
• Doing what needs to be done.
• Avoiding missing for unjustified reasons.
• Report failures and inappropriate behaviors.
• Taking care of yourself in order to avoid accident.
• Having a sense of urgency.
• Being hunger for self-improvement.
• Being willing for growing and improving.
• Finding solutions.
• Having forward thinking.
• Going after the “Yes, you can!”
